Theophylline
NDC 82638-106, Theophylline, tablet, extended release, from Harman Finochem Limited.
- Product NDC
- 82638-106
- Status
- Listed
- Labeler
- Harman Finochem Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214806
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82638-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS450 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82638-106-02 | 82638010602 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (82638-106-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/098db8bb-fa9a-4577-b7d9-86caaefc168a
Use it
Look up 82638-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82638-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82638-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.